Altitude Journal
The Journal
Deep dives into the science and culture of consciousness.
The Next Psilocybin Question Is Not Hype. It Is Evidence, Timing, and Review.
A regulatory-watch explainer on why the next phase of psilocybin medicine is about evidence, timing, and review rather than hype.
Fear Is Not a Character Flaw. It's Architecture.
And here's what I've learned about rewiring it — from the amygdala to meditation to psychedelics.
Three Paths to a Healthier Brain: Learning, Meditation, and Psychedelics
Why neuroscience says you need all three — and how to combine them safely.
Clinical vs. Consumer: Navigating the New Psilocybin Landscape
The same compound, very different experiences. Understanding the difference between clinical and consumer use is essential.
What Is Evidence-Based Healing? A Guide to Altitude Global's Standards
The healing and wellness space is experiencing a credibility crisis. Here's how Altitude evaluates practitioners.
The God Molecule and the Spilled Milk
How a single encounter with Bufo changed the way I move through the world.
The Clinical Revolution: Psilocybin and 5-MeO-DMT Move from Underground to Evidence-Based Medicine
Rigorous clinical trials are providing what decades of anecdotal evidence couldn't: peer-reviewed data showing these compounds may offer rapid, sustained relief.